肺癌患者化疗所致恶心呕吐预防流程的构建与实践

Development and practice of chemotherapy-induced nausea and vomiting prevention process management among lung cancer patients

目的探索肺癌患者化疗所致恶心呕吐预防流程的效果。方法将80例肺癌顺铂化疗患者根据入院时间分组,将2016年3-9月收治的40例患者作为对照组,2016年10月-2017年4月收治的40例患者作为观察组。对照组给予常规肿瘤化疗护理及健康教育,观察组实施化疗所致恶心呕吐预防流程管理。比较两组患者恶心、呕吐发生率及生活质量。结果观察组恶心、呕吐发生率明显低于对照组(P<0.05),而生活质量高于对照组(P<0.05)。结论化疗所致恶心呕吐预防流程管理能有效降低肺癌化疗患者恶心、呕吐发生率,提高患者的生活质量。

Objective To study the effect of chemotherapy induced nausea and vomiting （CINV） prevention process management among lung cancer patients. Methods Totally 80 lung cancer patients underwent cisplatin chem otherapy were divided according to chronological order, 40 patients admitted from March to September 2016 were treated as the control group, and 40 patients admitted from October 2016 to April 2017 were served as the interven tion group. The control group received regular nursing care and health guidance, while the intervention group was given the CINV prevention process management. The incidence of nausea, vomiting and the quality of life score be tween the two groups were compared. Results The incidence of nausea and vomiting of the intervention group was significantly lower than that of the control group（P〈0.05）, while the quality of life score was higher than that of the control group（P〈0.05）. Conclusion The CINV prevention process management could effectively reduce the inci dence of nausea and vomiting, and improve their quality of life.